Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study. (Record no. 10386043)

MARC details
000 -LEADER
fixed length control field 01494 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513190404.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199908s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1525-4135
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00126334-199908010-00014
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Jahnke, N
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990809
245 00 - TITLE STATEMENT
Title Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of acquired immune deficiency syndromes (1999)
Date of publication, distribution, etc. Aug 1999
300 ## - PHYSICAL DESCRIPTION
Extent 347-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-HIV Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element CD4 Lymphocyte Count
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV Infections
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV-1
General subdivision isolation & purification
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indinavir
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lamivudine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stavudine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Viremia
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Zidovudine
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yip, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hogg, R S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name O'Shaughnessy, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Montaner, J S
773 0# - HOST ITEM ENTRY
Title Journal of acquired immune deficiency syndromes (1999)
Related parts vol. 21
-- no. 4
-- p. 347-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00126334-199908010-00014">https://doi.org/10.1097/00126334-199908010-00014</a>
Public note Available from publisher's website

No items available.